Obermatt
See Similar Stocks →

Standard BioTools

NSQ:LAB · US34385P1084
Life Sciences Tools & ServicesSmall

360

60
EV / EBIT96
Price / Owner Earnings37
Owner Earnings Yield100
Dividend Yield1
Price/Sales38
Price/Book80
Return on Capital34
Cash Return on Capital94
Return on Equity46
EBIT Margin16
Gross Profitability12
Cash Conversion1
Accruals43
Owner Earnings Margin100
Sales growth23
Profit growth49
Reinvestment7
Price momentum44
Debt load98
Refinancing73
Debt Payback100
Liquidity4
Analyst ratings46
Opinion Changes5
Price Target Upside80
Market mood17
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Standard BioTools generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded1999
Employees444
Websitestandardbio.com
ISINUS34385P1084
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Health DiagnosticsImmunologyBiomedical EngineeringGeneticsOncology

Description

Standard BioTools Inc. (‘Standard BioTools’) develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers develop better therapeutics faster. The company’s tools p…

Analysis

Middle-of-the-road

Standard BioTools Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is attractive. The owner-earnings multiple stands at 4.2×; owner earnings: the cash an owner could take out each year.

Growth is moderate; the safety picture is adequate. The company scores 14/20 on our value-creation score: strong value creator.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
6
20232026

All-time high

42

Jan 2023

All-time low

6

Jun 2026

Average rank

24

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
38
—
—
91
Price/Earnings
3
—
—
30
Price/Book
80
—
—
91
Dividend Yield
1
—
—
1
Value (overall)
18
—
—
82

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Standard BioTools with its peers
10x Genomics
NSQ:TXG
38
CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →
Pacific Biosciences of California
NSQ:PACB
16
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Inotiv
NAQ:NOTV
16
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Revvity
NYQ:RVTY
52
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Bio-Rad Laboratories
NYQ:BIO
48
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Nautilus Biotechnology
NAQ:NAUT
26
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →